Estimate Recalculated Nov 4, 2024 02:33AM EST
Jesse I Treu does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Dicerna Pharmaceuticals Inc, Volcano Corp, Bionano Genomics, Inc., Orexigen Therapeutics, Inc., ZOGENIX, INC., TANDEM DIABETES CARE INC, CoLucid Pharmaceuticals, Inc., MARINUS PHARMACEUTICALS INC, GLAUKOS Corp, VERACYTE, INC., Atara Biotherapeutics, Inc., Aldeyra Therapeutics, Inc., Vanda Pharmaceuticals Inc., Syndax Pharmaceuticals Inc, Esperion Therapeutics, Inc., Clovis Oncology, Inc., NUVASIVE INC, Alliqua BioMedical, Inc., OBALON THERAPEUTICS INC, Evoke Pharma Inc, aTYR PHARMA INC, ALIMERA SCIENCES INC, OTONOMY, INC., Neothetics, Inc., NOVACEA INC, Durata Therapeutics, Inc., REVA Medical, Inc., SENOMYX INC, Ocera Therapeutics, Inc., CADENCE PHARMACEUTICALS INC, Somaxon Pharmaceuticals, Inc., Achaogen Inc, Regado Biosciences Inc, ACHILLION PHARMACEUTICALS INC, Celator Pharmaceuticals Inc, SANTARUS INC, SENORX INC, Northstar Neuroscience, Inc., IOMAI CORP, INTRALASE CORP, and INSPIRE PHARMACEUTICALS INC.
Jesse I Treu's CIK is 0001013425
2009 was Jesse I Treu's most active year for acquiring shares with 11 total transactions. Jesse I Treu's most active month to acquire stocks was the month of May. 2009 was Jesse I Treu's most active year for disposing of shares, totalling 5 transactions. Jesse I Treu's most active month to dispose stocks was the month of May. 2007 saw Jesse I Treu paying a total of $0.00 for 114,949 shares, this is the most they've acquired in one year. In 2007 Jesse I Treu cashed out on 29,186 shares for a total of $600,939.74, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!